The rapid evolution of biotechnological research has transitioned from the physical handling of biological samples to the sophisticated analysis of digital data, a shift that has prompted the International Chamber of Commerce (ICC) to issue an urgent call for a streamlined and legally certain global framework. As the international community prepares for the 17th Conference of the Parties (COP17) to the Convention on Biological Diversity (CBD), the private sector is emphasizing the need for a benefit-sharing mechanism that encourages innovation while ensuring that the utilization of Digital Sequence Information (DSI) contributes to global biodiversity conservation. The core of the debate lies in how to manage the vast repositories of genetic sequences—originating from plants, animals, and microorganisms—that are now stored in open-access databases and utilized across a multitude of industries, from pharmaceuticals and agriculture to cosmetics and climate-tech.
The Digital Transformation of Biological Research
For decades, the Convention on Biological Diversity and its supplementary agreement, the Nagoya Protocol, governed the "Access and Benefit-Sharing" (ABS) of physical genetic resources. Under these frameworks, researchers seeking to study a specific plant or microbe from a biodiverse nation were required to negotiate bilateral agreements, ensuring that a portion of the resulting benefits—whether financial or technical—returned to the provider country. However, the advent of high-throughput sequencing and bioinformatics has fundamentally altered this landscape. Today, a scientist can sequence a pathogenic virus or a drought-resistant crop in one country, upload that data to a public database, and a researcher on the other side of the planet can access that information digitally to develop a new vaccine or a more resilient seed variety without ever touching a physical sample.
This digital shift has created a regulatory vacuum. Existing national regulations, designed for physical transfers, are often ill-equipped to handle the fluid and global nature of digital data. Recognizing this gap, the CBD has been working toward a new global system to ensure that the benefits derived from DSI are shared fairly and equitably. The ICC, representing millions of businesses worldwide, argues that while the principle of benefit-sharing is sound, the implementation must be pragmatic to avoid stifling the very research that drives sustainable development.
Chronology of the DSI Negotiations: From Montreal to Cali
The path toward a global DSI mechanism has been marked by intense diplomatic negotiations. The journey gained significant momentum during COP15 in Montreal in 2022, where parties agreed to establish a multilateral mechanism for benefit-sharing from the use of DSI, including a global fund. This was a landmark decision, acknowledging that a bilateral, country-by-country approach to digital data would be administratively impossible and scientifically detrimental.
Following COP15, the focus shifted to the technicalities of how such a fund would work. During COP16 in Cali, Colombia, the "Cali Fund" was formally established. This fund is intended to receive contributions from users of DSI, which would then be distributed to support biodiversity conservation and sustainable use, particularly in developing nations and among Indigenous peoples and local communities. However, many of the operational details—such as who exactly must pay, how much they should pay, and what triggers a payment—were left for further refinement.
As the international community moves toward COP17, the stakes have never been higher. The ICC is now urging negotiators to prioritize "legal certainty, clarity, and proportionality." Without these elements, the business community warns that the mechanism could become a deterrent to research and development, potentially slowing down innovations needed to address the global biodiversity and climate crises.
The Economic Scale and Scientific Importance of DSI
To understand the urgency of the ICC’s call, one must consider the sheer scale of the bio-economy. According to industry estimates, the global biotechnology market was valued at over $1.5 trillion in 2023 and is expected to grow significantly over the next decade. Much of this value is predicated on the ability to access and analyze genetic data.
Public databases, such as those maintained by the International Nucleotide Sequence Database Collaboration (INSDC), contain billions of sequences. These databases are the lifeblood of modern science. For instance, during the COVID-19 pandemic, the rapid sharing of the SARS-CoV-2 genetic sequence allowed for the development of diagnostic tests and vaccines in record time. In agriculture, DSI is used to identify genes that allow crops to survive extreme heat or resist pests, which is critical for food security in a changing climate.
The ICC emphasizes that any mechanism that creates high barriers to accessing this data, or that imposes unpredictable financial burdens on its use, could disrupt these essential scientific pipelines. The business community is particularly concerned about "double-dipping," where a company might be required to pay into a global DSI fund while also being subject to conflicting or overlapping national benefit-sharing laws.
Industry Demands: Certainty, Proportionality, and Simplicity
The ICC has outlined a specific set of requirements to ensure that the DSI mechanism is both effective for conservation and viable for industry. At the forefront of these demands is the need for a "one-stop-shop" approach. Business leaders argue that a single, centralized global mechanism is far preferable to a fragmented landscape of 196 different national systems.
Business calls for a mechanism that:
- Provides a clear and exhaustive definition of what constitutes DSI to avoid legal ambiguity.
- Ensures that benefit-sharing obligations are triggered by specific, identifiable commercial milestones rather than the mere act of accessing a database.
- Avoids retroactive application, ensuring that research projects started before the mechanism’s implementation are not suddenly burdened with new costs.
- Maintains the open-access nature of public databases, which is essential for the "pre-competitive" phase of research where most scientific discoveries occur.
Furthermore, the ICC is urging COP17 negotiators to prioritize a system that is proportionate. This means that the financial contributions requested from businesses should reflect the actual value derived from the DSI and the size of the company. Small and medium-sized enterprises (SMEs), which are often the engines of innovation in the biotech sector, should not be disproportionately burdened by administrative or financial requirements.
Stakeholder Reactions and the Global Divide
The negotiations surrounding DSI are characterized by a complex interplay between the Global North and the Global South. Developing nations, which harbor the majority of the world’s biodiversity, argue that they have been historically excluded from the profits generated by their genetic resources. For these countries, a robust and mandatory DSI benefit-sharing mechanism is a matter of "biopiracy" prevention and social justice.
Conversely, many developed nations and their respective industry bodies worry that a mandatory, high-cost system will drive R&D investment away from biological resources altogether, leading scientists to use synthetic or non-biological alternatives. The scientific community, represented by organizations like the DSI Scientific Network, has also voiced concerns that any restriction on data flow could hamper international collaboration and the monitoring of emerging infectious diseases.
The ICC’s role is to bridge this gap by proposing a system that businesses can realistically comply with. By advocating for a mechanism that is "attractive to business," the ICC suggests that a voluntary or highly streamlined mandatory system would actually result in more funds being generated for conservation than a complex, punitive system that companies seek to bypass.
Analysis of Implications: The Road to COP17
The success of COP17 will likely hinge on whether negotiators can move past ideological differences to build a functional administrative structure for the Cali Fund. If the mechanism is too broad—covering too many types of data or imposing too many duplicate obligations—it risks alienating the private sector. If it is too narrow or weak, it will fail to meet the expectations of the Global South and will not generate the billions of dollars needed to meet the goals of the Kunming-Montreal Global Biodiversity Framework.
The ICC also calls attention to the importance of "capacity building." For the DSI mechanism to be truly equitable, it must do more than just collect and distribute money. It must also involve the transfer of technology and expertise to developing nations so they can participate in the digital bio-economy themselves.
As governments move to operationalize the DSI mechanism, the global business community remains a critical stakeholder. The ICC’s message is clear: the private sector is willing to contribute to biodiversity conservation, but it requires a regulatory environment that is predictable and grounded in the realities of modern research. Expanding the mechanism to cover more countries and a broader range of materials could indeed be a path forward, provided that the principles of legal certainty and proportionality remain the foundation of the agreement.
In the coming months, the dialogue between policy makers and industry representatives will intensify. The outcome at COP17 will determine whether the digital revolution in biology becomes a tool for global equity and conservation, or a source of legal and economic friction that slows the pace of global innovation. The ICC’s call for a pragmatic, business-friendly framework serves as a reminder that the most effective environmental policies are often those that align economic incentives with the urgent need to protect the natural world.
About the Author
